Burning Rock Biotech (BNR) Operating Margin: 2020-2025
Historic Operating Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 12.22%.
- Burning Rock Biotech's Operating Margin rose 2174.00% to 12.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.49%, marking a year-over-year increase of 6561.00%. This contributed to the annual value of 69.32% for FY2024, which is 5522.00% up from last year.
- As of Q3 2025, Burning Rock Biotech's Operating Margin stood at 12.22%, which was down 57.10% from 7.78% recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Operating Margin registered a high of 7.78% during Q2 2025, and its lowest value of 203.45% during Q2 2022.
- Moreover, its 3-year median value for Operating Margin was 81.95% (2024), whereas its average is 73.73%.
- Per our database at Business Quant, Burning Rock Biotech's Operating Margin crashed by 5,523bps in 2021 and then skyrocketed by 11,293bps in 2023.
- Burning Rock Biotech's Operating Margin (MRQ) stood at 170.61% in 2021, then rose by 9bps to 155.21% in 2022, then rose by 12bps to 135.95% in 2023, then surged by 53bps to 64.21% in 2024, then soared by 81bps to 12.22% in 2025.
- Its last three reported values are 12.22% in Q3 2025, 7.78% for Q2 2025, and 11.41% during Q1 2025.